• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Medical Device Problem Codes Activation, Positioning or Separation Problem (2906); Material Deformation (2976); Positioning Problem (3009)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/09/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that partial deployment and stent deformation occurred.Vascular access was gained via contralateral approach.The target lesion was located in the chronic total occluded superficial femoral artery (sfa).A 7x150, 130 cm eluvia drug-eluting vascular stent system was selected for use.During the procedure, the thumbwheel was turned with high force and the stent deployed 120mm.There was 3cm of the stent that did not deploy.The deployment handle was opened and the brown hypotube was attempted to be pulled back.It was noted that the hypotube was bunched up inside the deployment handle.The whole deployment system was attempted to be removed which only stretched out the stent 4cm.Ultimately, it was discovered that deployment of the stent occurred inside the guide sheath.The sheath was pulled back allowing the stent to deploy partially in the intended location.The delivery system was removed from the patient manually.The stent was post dilated.The physician stated the ro marker on the sheath was mistaken as the stent ro marker.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20139096
Report Number2124215-2024-54207
Device Sequence Number3101331
Product Code NIU
UDI-Device Identifier08714729876748
UDI-Public08714729876748
Combination Product (Y/N)Y
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/07/2026
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0033782490
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/09/2024
Initial Report FDA Received Date09/04/2024
Date Device Manufactured03/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDEWIRE: 014
Patient SexUnknown
-
-